Tailor Bio Ltd (12229006) is a private limited with share capital incorporated on 26/09/2019 (6 years old) and registered in oakham, LE157WD. The company operates under SIC code 72110 and is classified as Small.
Tailor bio is developing an ai-driven drug discovery platform for pan-cancer precision medicine. we're doing this by focussing on chromosomal instability, a genomic phenomenon present in 80% of all cancers.
Termination Director Company With Name Termination Date
Category:Officers
Date:19-03-2025
Termination Director Company With Name Termination Date
Category:Officers
Date:19-03-2025
Capital Allotment Shares
Category:Capital
Date:15-01-2025
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:04-07-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:28-03-2024
Change Person Director Company With Change Date
Category:Officers
Date:28-03-2024
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:26-03-2024
Change Person Director Company With Change Date
Category:Officers
Date:25-03-2024
Change Person Director Company With Change Date
Category:Officers
Date:25-03-2024
Change Person Director Company With Change Date
Category:Officers
Date:25-03-2024
Change Person Director Company With Change Date
Category:Officers
Date:25-03-2024
Change Person Director Company With Change Date
Category:Officers
Date:28-02-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:30-01-2024
Change Account Reference Date Company Previous Shortened
Category:Accounts
Date:31-10-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:21-03-2023
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:20-03-2023
Change Person Director Company With Change Date
Category:Officers
Date:19-03-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:10-01-2023
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:12-12-2022
Change Person Director Company With Change Date
Category:Officers
Date:12-12-2022
Change Person Director Company With Change Date
Category:Officers
Date:12-12-2022
Resolution
Category:Resolution
Date:30-11-2022
Capital Alter Shares Subdivision
Category:Capital
Date:30-11-2022
Memorandum Articles
Category:Incorporation
Date:30-11-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:29-11-2022
Capital Allotment Shares
Category:Capital
Date:29-11-2022
Capital Allotment Shares
Category:Capital
Date:29-11-2022
Capital Allotment Shares
Category:Capital
Date:29-11-2022
Capital Allotment Shares
Category:Capital
Date:29-11-2022
Capital Allotment Shares
Category:Capital
Date:29-11-2022
Capital Allotment Shares
Category:Capital
Date:29-11-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:08-11-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:08-11-2022
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:04-11-2022
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:04-11-2022
Withdrawal Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:04-11-2022
Change Person Director Company With Change Date
Category:Officers
Date:12-04-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:12-04-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:19-08-2021
Change Account Reference Date Company Previous Shortened
Category:Accounts
Date:01-07-2021
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:01-06-2021
Change Person Director Company With Change Date
Category:Officers
Date:19-04-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:19-04-2021
Change Person Director Company With Change Date
Category:Officers
Date:19-04-2021
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:04-02-2021
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:19-06-2020
Resolution
Category:Resolution
Date:17-06-2020
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:12-06-2020
Capital Allotment Shares
Category:Capital
Date:12-06-2020
Change Person Director Company With Change Date
Category:Officers
Date:19-05-2020
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:19-05-2020
Change Person Director Company With Change Date
Category:Officers
Date:19-05-2020
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:19-05-2020
Resolution
Category:Resolution
Date:27-04-2020
Confirmation Statement With Updates
Category:Confirmation Statement
Date:10-04-2020
Change Person Director Company With Change Date
Category:Officers
Date:10-04-2020
Change Person Director Company With Change Date
Category:Officers
Date:08-04-2020
Change Person Director Company With Change Date
Category:Officers
Date:08-04-2020
Appoint Person Director Company With Name Date
Category:Officers
Date:08-04-2020
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:08-04-2020
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:08-04-2020
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:08-04-2020
Appoint Person Director Company With Name Date
Category:Officers
Date:08-04-2020
Appoint Person Director Company With Name Date
Category:Officers
Date:08-04-2020
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:05-03-2020
Incorporation Company
Category:Incorporation
Date:26-09-2019
Innovate Grants
2
This company received a grant of £67387.6 for Whole Genome Sequencing Of Liquid Biopsies To Predict Doxorubicin Response In Ovarian Cancer. The project started on 01/09/2020 and ended on 31/07/2021.
This company received a grant of £353947.01 for Improving Doxorubicin Treatment In Ovarian Cancer. The project started on 01/04/2022 and ended on 31/03/2024.
Risk Assessment
low risk
International Score
Future Factor
excellent
Performance Rating
Accounts
Typetotal exemption full
Due Date31/12/2026
Filing Date17/07/2025
Latest Accounts31/03/2025
Trading Addresses
Ketton Suite, The King Centre,, Main Road, Oakham, Rutland Le15 7Wd, LE157WDRegistered